Core Tip: Drugmakers worldwide face growing scrutiny over their research pipelines, as valuations increasingly depend on successful late-stage trials rather tha
Drugmakers worldwide face growing scrutiny over their research pipelines, as valuations increasingly depend on successful late-stage trials rather than blockbuster drugs nearing patent expiry.
2026-10-30
FMT
5